CM. Read why NTLA stock has potential with upcoming 2025 data and a growing $12B market for Transthyretin Amyloidosis.

A study has demonstrated the high accuracy of plasma p-tau217 as a blood-based biomarker for detecting abnormal brain beta-amyloid pathology, a hallmark of Alzheimer's disease.

Age-related macular degeneration, or AMD, is a common eye condition and also a leading cause of vision ... The first similar ...